Furlani, Lara
 Distribuzione geografica
Continente #
NA - Nord America 196
AS - Asia 148
EU - Europa 129
SA - Sud America 23
AF - Africa 2
OC - Oceania 2
Totale 500
Nazione #
US - Stati Uniti d'America 194
CN - Cina 57
SG - Singapore 54
GB - Regno Unito 32
IT - Italia 20
BR - Brasile 19
FR - Francia 17
HK - Hong Kong 15
SE - Svezia 12
DE - Germania 10
FI - Finlandia 10
RU - Federazione Russa 9
BE - Belgio 7
IN - India 6
VN - Vietnam 6
IE - Irlanda 4
AR - Argentina 3
ID - Indonesia 3
NL - Olanda 3
AU - Australia 2
CA - Canada 2
IQ - Iraq 2
KR - Corea 2
AT - Austria 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
IR - Iran 1
LK - Sri Lanka 1
NG - Nigeria 1
PL - Polonia 1
TG - Togo 1
UA - Ucraina 1
Totale 500
Città #
Dallas 31
Chandler 27
Singapore 26
Southend 26
Woodbridge 20
Ann Arbor 16
Ashburn 14
Hong Kong 14
Wilmington 11
Beijing 10
New York 10
Brussels 7
Falls Church 6
Hebei 5
Shenyang 5
Dublin 4
Helsinki 4
Lawrence 4
Los Angeles 4
Princeton 4
São Paulo 4
Zhengzhou 4
Asiago 3
Guangzhou 3
Hyderabad 3
Jakarta 3
Jinan 3
Nanjing 3
Verona 3
Vicenza 3
Wuhan 3
Boardman 2
Columbus 2
Dong Ket 2
Frankfurt am Main 2
Paris 2
Redmond 2
Redwood City 2
Santa Clara 2
Sommacampagna 2
Taizhou 2
The Dalles 2
Tianjin 2
Turku 2
Xi'an 2
Amsterdam 1
Andover 1
Arlington Heights 1
Atlanta 1
Baghdad 1
Belo Horizonte 1
Bexley 1
Buenos Aires 1
Canoas 1
Caratinga 1
Changzhou 1
Charlotte 1
Chions 1
Chiusa 1
Clifton 1
Colombo 1
Guaratinguetá 1
Gummersbach 1
Hefei 1
Jacksonville 1
Jales 1
Kochi 1
Lanús 1
Lomé 1
Martignacco 1
Milan 1
Minsk 1
Mira 1
Montreal 1
Mumbai 1
Munich 1
Norwalk 1
Oliveira 1
Orizona 1
Pergamino 1
Ribeirão Preto 1
Rolante 1
Salvador 1
San Francisco 1
San Jose 1
Santo André 1
Sarandi 1
Sindelfingen 1
Sulaymaniyah 1
Sydney 1
São Leopoldo 1
São Vicente 1
Tallinn 1
Vila Boa 1
Warsaw 1
Totale 361
Nome #
slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP 138
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 110
Psychological impact of Covid-19 pandemic on oncological patients: a survey in Northern Italy 94
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. 93
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements 73
Totale 508
Categoria #
all - tutte 1.837
article - articoli 1.157
book - libri 0
conference - conferenze 680
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 3 4 4 0 0 1 1 0 4 8
2021/202270 8 16 1 1 8 9 1 2 5 1 8 10
2022/202365 5 8 9 14 4 16 1 1 7 0 0 0
2023/202453 0 8 2 6 9 11 0 3 1 3 7 3
2024/2025150 4 8 15 28 6 10 6 4 22 8 16 23
2025/202659 22 35 2 0 0 0 0 0 0 0 0 0
Totale 508